TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants June 27, 1975
